Overview

OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb Spasticity

Status:
Terminated
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
This is a safety and efficacy study of onabotulinumtoxinA in poststroke patients with upper limb spasticity.
Phase:
Phase 3
Details
Lead Sponsor:
Allergan
Treatments:
abobotulinumtoxinA
Botulinum Toxins
Botulinum Toxins, Type A
incobotulinumtoxinA
onabotulinumtoxinA